Medtronic (MDT) Falls More Steeply Than Broader Market: What Investors Need to Know
Medtronic (MDT) concluded the recent trading session at $82.38, signifying a -0.42% move from its prior day's close.
Medtronic (MDT) Up 2.9% Since Last Earnings Report: Can It Continue?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Why Medtronic Stock Topped the Market on Thursday
The medical-device giant won approval for a device that combats irregular heartbeats. The FDA gave the green light to the PulseSelect PFA System.
Medtronic receives FDA approval for heart condition treatment; shares rise
Medtronic PLC (NYSE:MDT) late Wednesday announced that the US Food and Drug Administration (FDA) has approved its PulseSelect Pulsed Field Ablation (PFA) system for the treatment of two heart condi...
Medtronic gets FDA approval for new heart-condition treatment
Medtronic said the U.S. Food and Drug Administration has approved its PulseSelect Pulsed Field Ablation System for the treatment of two heart conditions.
Medtronic (MDT) Expands AI-Driven Care With New Partnership
Medtronic's (MDT) expanded collaboration with Cosmo Pharmaceuticals is a strategic step forward in its quest to use AI to improve patient care.
Medtronic: The GLP-1 Drug Headwinds Are Overblown
Mr. Market has overemphasized the potential negative impacts of GLP-1 drugs on conventional diabetes care since there is no miracle one-time drug. Medtronic's bottom lines have also been impacted b...
Solid as a Rock: 3 Blue-Chip Stocks for a Stable Portfolio
It's understandable if you have whiplash from market moves this year. We've seen stocks surge, fall and surge again on the heels of the current Santa rally.
Medtronic: On The Verge Of A Massive Turnaround
Medtronic's recent earnings report has boosted investor confidence, suggesting the worst may be over for the company. The impact of the weight loss drugs on Medtronic's long-term growth prospects i...
If You Can Only Buy One Tech Stock in December, It Better Be One of These 3 Names
The top tech stocks are always a point of contention among investors. Some prefer sticking with reliable companies like the Magnificent 7, while others decry the same for being grossly overvalued.
3.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic
Medtronic is a well-diversified healthcare company with strong secular growth and pricing power. The company has four major business segments, each contributing over $2 billion in annual revenue. M...
3 Top-Rated Value Stocks That Analysts Are Loving Now
The stock market is enjoying some holiday cheer. Amid signs that inflation is letting up and the Federal Reserve may finally put an end to its rate hikes, traders are piling into all sorts of inves...
Is Medtronic a Good Dividend Stock to Buy Now?
Medtronic has a history of raising its dividend rapidly, but its pace has slowed down. Fiscal second-quarter sales earnings fell slightly, and the company's predictions for the next six months aren...
Medtronic: oversold, overextended high yield reversal in play
After two years of correction and downtrend, providing ample incentive to buyers all along the way, medical device maker Medtronic NYSE: MDT has finally reached its bottom, and the reversal is on. ...
Why Medtronic Stock Trounced the Market on Tuesday
The medical-devices specialist published its latest set of quarterly results. Happily for its shareholders, the company managed to grow on both the top and bottom lines and beat analyst estimates.
Related Companies